Eli Lilly and Company
NYSE:LLY
$ 777.36
$-3.96 (-0.52%)
$ 777.36
$-3.96 (-0.52%)
Real-time: 03/01/2024 13:44

LLY - Eli Lilly and Stock Prediction 2025 - 2030

20 years of reliable Eli Lilly and stock forecast. The Wall Street analysts predict Outperform for LLY. See at a glance whether NYSE:LLY will rise in the future.

$209.32
Forecast 2023
$449.64
Forecast 2025
$639.99
Forecast 2030
Neutral
TopGraphs Quality Ranking
Forecast 2023
$209.32
Forecast 2025
$449.64
Forecast 2030
$639.99
TopGraphs Quality Ranking
Neutral

Company Info

P/E
0.00
Beta
0.32
Price-to-book Ratio
62.91
Market Cap
678.44B
TEV
694.25 B
Dividend
$5.20
Div Yld
0.69%
Forecast 1Y
-47.63%
Forecast 2Y
-26.12%
Analyst Price Target
$636.99

Eli Lilly and Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Eli Lilly and Stock Forecast 2023

$800.00

In the last five quarters, Eli Lilly and’s Price Target has risen from $277.47 to $636.99 - a 129.57% increase. Twenty-four analysts predict that Eli Lilly and’s share price will increase in the coming year, reaching $800.00. This would represent an increase of 25.59%.

6.15%
6.15
Last update: 03/01/2024

Highest Price Target $950.00

Average Price Target $800.00

Lowest Price Target $500.00

Eli Lilly and Stock Prediction 2025

Eli Lilly and Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of $377.75. A decrease of -49.88% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of $384.29. A decrease of -49.01% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of $390.82. A decrease of -48.14% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of $397.36. A decrease of -47.28% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of $403.89. A decrease of -46.41% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of $410.43. A decrease of -45.54% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of $416.96. A decrease of -44.68% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of $423.50. A decrease of -43.81% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of $430.03. A decrease of -42.94% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of $436.57. A decrease of -42.08% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of $443.10. A decrease of -41.21% compared to the previous month's estimate.

Eli Lilly and Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of $449.64. A decrease of -40.34% compared to the previous month's estimate.

Eli Lilly and Stock Forecast 2030

Stock Forecast for the Price of an Eli Lilly and Share in Jan 2030.

In January 2030, analysts believe the stock price will be $615.35. A decrease of -18.35% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Feb 2030.

In February 2030, analysts believe the stock price will be $617.59. A decrease of -18.06% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Mar 2030.

In March 2030, analysts believe the stock price will be $619.83. A decrease of -17.76% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Apr 2030.

In April 2030, analysts believe the stock price will be $622.07. A decrease of -17.46% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in May 2030.

In May 2030, analysts believe the stock price will be $624.31. A decrease of -17.17% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Jun 2030.

In June 2030, analysts believe the stock price will be $626.55. A decrease of -16.87% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Jul 2030.

In July 2030, analysts believe the stock price will be $628.79. A decrease of -16.57% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Aug 2030.

In August 2030, analysts believe the stock price will be $631.03. A decrease of -16.27% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Sep 2030.

In September 2030, analysts believe the stock price will be $633.27. A decrease of -15.98% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Oct 2030.

In October 2030, analysts believe the stock price will be $635.51. A decrease of -15.68% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Nov 2030.

In November 2030, analysts believe the stock price will be $637.75. A decrease of -15.38% compared to the previous month's estimate.

Stock Forecast for the Price of an Eli Lilly and Share in Dec 2030.

In December 2030, analysts believe the stock price will be $639.99. A decrease of -15.08% compared to the previous month's estimate.

P/E
0.00
Beta
0.32
Price-to-book Ratio
62.91
Market Cap
678.44B
TEV
694.25 B
Dividend
$5.20
Div Yld
0.69%
Forecast 1Y
-47.63%
Forecast 2Y
-26.12%
Analyst Price Target
$636.99

Eli Lilly and Analyst Ratings Frequently Asked Questions

Who are the analysts watching Eli Lilly and Company?

The following analysts have recently covered Eli Lilly and:

Argus Research Company
Baptista Research
Barclays
Berenberg
BMO Capital Markets Equity Research
BofA Global Research
Cantor Fitzgerald & Co.
CFRA Equity Research
Citigroup Inc
Citigroup Inc. Research
Daiwa Securities Co. Ltd.
Evercore ISI
Goldman Sachs
Guggenheim Securities, LLC
J.P. Morgan
Marktfeld
Mirae Asset Securities Co., Ltd.
Morgan Stanley
Morningstar Inc.
Societe Generale Cross Asset Research
Truist Securities
Wells Fargo Securities, LLC
Wolfe Research, LLC.
UBS Investment Bank
Capital Alpha Partners, LLC
CFRA Policy Research
China International Capital Corporation Limited
Crisp Idea
Deutsche Bank
Eugene Investment & Securities Co Ltd.
Jefferies LLC
Leerink Partners LLC
NH Investment & Securities Co., Ltd.
Redburn Atlantic
S&P Global Ratings
TD Cowen
William O'Neil + Co., Incorporated
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Eli Lilly and Company?

The following sell-side analysts have recently covered Eli Lilly and:

Chesney, Steven Kent
Majumdar, Ishan
Gould, Carter Lewis
Holford, Kerry Ann
Seigerman, Evan David
Meacham, Geoffrey Christopher
Chen, Louise Alesandra
Baum, Andrew Simon
Scala, Stephen Michael
Nakagiri, Narumi
Fernandez, Seamus Christopher
Schott, Christopher Thomas
Paraskevopoulos, Michail
Conover, Damien
Cespedes, Florent
Karnauskas, Robyn Kay Shelton
Bansal, Mohit
Anderson, Timothy Minton
Flynn, Terence C.
Hellweg, Jasper
Risinger, David Reed
Raffat, Umer
Monk, Kimberly D.
Hardy, Sel
Leppard, John J.
Murarka, Rimi
Shin, James John
Kwon, Haesoon
Tewari, Akash
Han, Wei
Zari, Scott
Gupta, Rajan
Shibutani, Chris
Huynh, Trung Chuong
Qu, Xiaoyi
Kim, Seung-min
(This information refers to the last 90 days.)